Burden of disease and current management of dementia with Lewy bodies: a literature review
AA Tahami Monfared, G Meier, R Perry, D Joe - Neurology and Therapy, 2019 - Springer
Introduction A significant proportion of dementia is concretely estimated to be attributable to
dementia with Lewy bodies (DLB)—one of the most common types of progressive dementia; …
dementia with Lewy bodies (DLB)—one of the most common types of progressive dementia; …
Association of longitudinal β-amyloid accumulation determined by positron emission tomography with clinical and cognitive decline in adults with probable Lewy body …
Z Nedelska, CG Schwarz, TG Lesnick… - JAMA network …, 2019 - jamanetwork.com
Importance In patients with probable dementia with Lewy bodies (DLB), overlapping
Alzheimer disease pathology is frequent and is associated with faster decline and shorter …
Alzheimer disease pathology is frequent and is associated with faster decline and shorter …
Trinity-Simply: These three are one
A Van de Beek - Verbum et Ecclesia, 2022 - scielo.org.za
Trinity has been one of the core topics of theology during the last half century. Especially, the
idea of a social Trinity has been promoted by leading theologians. This interpretation of the …
idea of a social Trinity has been promoted by leading theologians. This interpretation of the …
A longitudinal study of neurocognition in dementia with Lewy bodies compared to Alzheimer's disease
MH Breitve, LJ Chwiszczuk, K Brønnick… - Frontiers in …, 2018 - frontiersin.org
Introduction There are relatively few longitudinal studies on the differences in cognitive
decline between Alzheimer's disease (AD) and dementia with Lewy bodies (DLB), and the …
decline between Alzheimer's disease (AD) and dementia with Lewy bodies (DLB), and the …
Subjective experience of time in dementia with Lewy bodies during COVID-19 lockdown
Dementia with Lewy bodies (DLB) is a neurodegenerative disease characterized by
cognitive, behavioral and motor symptoms and has a more challenging clinical management …
cognitive, behavioral and motor symptoms and has a more challenging clinical management …
Prospective predictors of decline v. stability in mild cognitive impairment with Lewy bodies or Alzheimer's disease
BackgroundMild cognitive impairment (MCI) may gradually worsen to dementia, but often
remains stable for extended periods of time. Little is known about the predictors of decline to …
remains stable for extended periods of time. Little is known about the predictors of decline to …
Complex I reductions in the nucleus basalis of Meynert in Lewy body dementia: the role of Lewy bodies
Neurons of the nucleus basalis of Meynert (nbM) are vulnerable to Lewy body formation and
neuronal loss, which is thought to underlie cognitive dysfunction in Lewy body dementia …
neuronal loss, which is thought to underlie cognitive dysfunction in Lewy body dementia …
European DLB consortium: diagnostic and prognostic biomarkers in dementia with Lewy bodies, a multicenter international initiative
K Oppedal, MG Borda, D Ferreira… - Neurodegenerative …, 2019 - Future Medicine
As the population ages, the incidence of chronic diseases such as dementia increases.
Dementia with Lewy bodies (DLB) is the second most common neurodegenerative dementia …
Dementia with Lewy bodies (DLB) is the second most common neurodegenerative dementia …
Parkinson's disease in Romania: A scoping review
EC Rosca, R Tudor, A Cornea, M Simu - Brain Sciences, 2021 - mdpi.com
Parkinson's disease (PD) is a significant cause of disability, with a fast-growing prevalence.
This review summarizes the epidemiological and clinical data, research on the diagnostic …
This review summarizes the epidemiological and clinical data, research on the diagnostic …
Dementia with Lewy bodies: emerging drug targets and therapeutics
ED Pope, L Cordes, J Shi, Z Mari… - Expert opinion on …, 2021 - Taylor & Francis
ABSTRACT Introduction: Dementia with Lewy bodies (DLB) is characterized by the toxic
accumulation of α-synuclein protein inside neural cells; this results in neurodegeneration …
accumulation of α-synuclein protein inside neural cells; this results in neurodegeneration …